The role of the immune system in the development of endometriosis

M Abramiuk, E Grywalska, P Małkowska, O Sierawska… - Cells, 2022 - mdpi.com
Endometriosis is a chronic disease that affects about 10% of women of reproductive age. It
can contribute to pelvic pain, infertility or other conditions such as asthma, cardiovascular …

CTLA-4: From mechanism to autoimmune therapy

A Hosseini, T Gharibi, F Marofi, Z Babaloo… - International …, 2020 - Elsevier
CD28 and CTLA-4 are both important stimulatory receptors for the regulation of T cell
activation. Because receptors share common ligands, B7. 1 and B7. 2, the expression and …

Beyond T-cells: functional characterization of CTLA-4 expression in immune and non-immune cell types

D Oyewole-Said, V Konduri, J Vazquez-Perez… - Frontiers in …, 2020 - frontiersin.org
The immune response consists of a finely-tuned program, the activation of which must be
coupled with inhibitory mechanisms whenever initiated. This ensures tight control of …

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies

KS Peggs, SA Quezada, CA Chambers… - Journal of Experimental …, 2009 - rupress.org
Cytotoxic T lymphocyte–associated antigen 4 (CTLA-4) is a critical negative regulator of
immune responses. Uniquely among known inhibitory receptors, its genetic ablation results …

CTLA-4 blockade in tumor models: an overview of preclinical and translational research

JF Grosso, MN Jure-Kunkel - Cancer immunity, 2013 - AACR
Cytotoxic T lymphocyte antigen-4 (CTLA-4) is a key negative regulator of T cell activation. A
complex integration of positive and negative co-stimulatory signals in the well-defined B7 …

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

GQ Phan, JC Yang, RM Sherry… - Proceedings of the …, 2003 - National Acad Sciences
Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) is a critical immunoregulatory
molecule (expressed on activated T cells and a subset of regulatory T cells) capable of down …

CTLA-4: new insights into its biological function and use in tumor immunotherapy

JG Egen, MS Kuhns, JP Allison - Nature immunology, 2002 - nature.com
The discovery of multiple costimulatory cell surface molecules that influence the course of T
cell activation has increased our appreciation of the complexity of the T cell response. It …

Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti–cytotoxic T-lymphocyte antigen-4

P Attia, GQ Phan, AV Maker, MR Robinson… - Journal of Clinical …, 2005 - ascopubs.org
Purpose Previously, we reported our experience treating 14 patients with metastatic
melanoma using a fully human antibody to cytotoxic T-lymphocyte antigen-4 (anti–CTLA-4) …

Advances in immunotherapy delivery from implantable and injectable biomaterials

DG Leach, S Young, JD Hartgerink - Acta biomaterialia, 2019 - Elsevier
Macroscale biomaterials, such as preformed implantable scaffolds and injectable soft
materials, possess powerful synergies with anti-cancer immunotherapies. Immunotherapies …

Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity

AM Paterson, SB Lovitch, PT Sage, VR Juneja… - Journal of Experimental …, 2015 - rupress.org
Cytotoxic T lymphocyte antigen-4 (CTLA-4) is an essential negative regulator of T cell
responses. Germline Ctla4 deficiency is lethal, making investigation of the function of CTLA …